Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin’s lymphoma and Hodgkin’s disease-Reference-Cited by-同舟云学术

Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin’s lymphoma and Hodgkin’s disease

Published:2003-05 Issue: Volume:14 Page:i11-i16
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Hertzberg M.S.,Crombie C.,Benson W.,Taper J.,Gottlieb D.,Bradstock K.F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/14/suppl_1/i11/398474/mdg703.pdf

Reference25 articles.

1. High-dose chemotherapy and ASCT for aggressive NHL;Vose;J Clin Oncol,1993

2. The role of intensive therapy and ASCT for chemotherapy sensitive relapsed and primary refractory NHL: identification of major prognostic groups;Prince;Br J Haematol,1996

3. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemo-poietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s disease: a randomised trial;Schmitz;Lancet,2002

4. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomized trial;Linch;Lancet,1993

5. Treatment of patients with relapsed and resistant NHL using total body irradiation, etoposide and cyclophosphamide and ABMT;Gulati;J Clin Oncol,1992

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fifteen year Follow-up of Relapsed/ Refractory Patients with Hodgkin Lymphoma Treated with Autologous Hematopoietic Stem Cell Transplantation;Journal of Stem Cell Therapy and Transplantation;2024-07-02

2. Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease;American Society of Clinical Oncology Educational Book;2024-06

3. An evidence-based and risk-adapted GSF versus GSF plus plerixafor mobilization strategy to obtain a sufficient CD34+ cell yield in the harvest for autologous stem cell transplants;Translational Oncology;2024-01

4. Hematopoietic Cell Transplantation for Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy;Cancers;2023-09-11